QGEN logo

Qiagen N.V. (QGEN)

Profile

Full Name

Qiagen N.V.

Ticker

NYSE: QGEN

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

Netherlands

IPO

June 28, 1996

Indexes

Not included

Website

http://www.qiagen.com

Employees

5700

Key Details

Price

$51.79(+1.09%)

Market cap

Last Dividend

$0.25

TTM Dividend yield

2.92%

Annual revenue

$1.98B(+0.66% YoY)

Annual EPS

$0.38(-75.00% YoY)

PE ratio

126.32

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $51.79
    QGEN price is $51.79

    30-Day Relative Volume

    0.83
    QGEN 30-day relative volume is 0.83

    Price Performance

    Price Most recent change

    +1.09%
    QGEN price was up +1.09% on Jul 25, 2025

    Price YTD change

    +16.3%
    QGEN price is up +16.3% since January 1st

    Price 1-year change

    +22.61%
    QGEN price is up +22.61% year-on-year

    Price 3-year change

    +9.26%
    QGEN price is up +9.26% over the past 3 years

    Price Range

    Price All-time high

    $60.81
    QGEN price is currently -14.83% below its historical high of $60.81

    Price 3-year low

    $34.74
    QGEN price is currently +49.08% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $11.22B
    QGEN market capitalization is $11.22 billion

    Market cap 3-year change

    +10.19%
    QGEN market capitalization is up +10.19% over the past 3 years

    Market cap All-time high

    $12.25B
    QGEN market capitalization is currently -8.47% below its historical high of $12.25 billion

    Market cap sector rank

    92.99%
    QGEN market capitalization is higher than 92.99% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.22%
    QGEN shares outstanding is up +0.22% year-on-year

    Shares Outstanding 3-Year Change

    +0.85%
    QGEN shares outstanding is up +0.85% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.58
    QGEN beta is 0.58

    200-day SMA

    $43.42
    QGEN price is currently +19.26% above its 200-day simple moving average

    50-day SMA

    $46.53
    QGEN price is currently +11.30% above its 50-day simple moving average

    RSI

    76.03
    QGEN 14-day relative strength index is 76.03

    Volume

    0.83
    QGEN 30-day relative volume is 0.83

    ATR

    $0.92
    QGEN average true range is $0.92

    10-day Historical Volatility

    22.10%
    QGEN 10-day historical volatility is 22.10%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.25
    QGEN last dividend was $0.25 per share, with an ex-dividend date of July 2, 2025

    Next Dividend

    -
    QGEN next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $1.32
    QGEN annual dividend per share is $1.32

    Dividend per share Sector Rank

    52.94%
    QGEN annual dividend per share is higher than 52.94% of companies in Healthcare sector

    Dividend per share 1-Year Change

    -
    QGEN annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    QGEN annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    2.54%
    QGEN annual dividend yield is 2.54%

    Dividend yield Sector Rank

    61.9%
    QGEN annual dividend yield is higher than 61.9% of companies in Healthcare sector

    Other

    Payout ratio

    -
    QGEN annual payout ratio value is unknown

    Dividends paid

    -
    QGEN annual dividends paid value is unknown

    Free cash flow

    $502.31M
    QGEN annual free cash flow is $502.31 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.98B
    QGEN annual revenue is $1.98 billion

    Revenue Analysts estimate

    $2.07B
    QGEN annual revenue is currently -4.40% lower than the consensus analysts' forecast

    Revenue 1-year change

    +0.66%
    QGEN annual revenue is up +0.66% year-on-year

    Revenue Sector rank

    84.46%
    QGEN annual revenue is higher than 84.46% of companies in Healthcare sector

    EPS

    EPS

    $0.38
    QGEN annual earnings per share is $0.38

    EPS Analysts estimate

    $2.36
    QGEN annual earnings per share is currently -83.87% lower than the consensus analysts' forecast

    EPS 1-year change

    -75%
    QGEN annual earnings per share is down -75% year-on-year

    EPS Sector rank

    86.22%
    QGEN annual earnings per share is higher than 86.22% of companies in Healthcare sector

    Profit

    Gross profit

    $967.35M
    QGEN annual gross profit is $967.35 million

    Gross margin

    48.90%
    QGEN annual gross profit margin is 48.90%

    Operating profit

    $199.90M
    QGEN annual operating income is $199.90 million

    Operating margin

    10.11%
    QGEN annual operating profit margin is 10.11%

    Net income

    $83.59M
    QGEN annual net profit is $83.59 million

    Net margin

    4.23%
    QGEN annual net profit margin is 4.23%

    Expenses

    Total expenses

    $1.78B
    QGEN annual total expenses is $1.78 billion

    Operating expenses

    $767.45M
    QGEN annual total operating expenses is $767.45 million

    Cost of goods sold

    $1.01B
    QGEN annual cost of goods sold is $1.01 billion

    Selling, general & administrative expenses

    $564.36M
    QGEN annual SGA is $564.36 million

    Depreciation and amortization

    $203.27M
    QGEN annual depreciation & amortization is $203.27 million

    Interest expense

    $43.84M
    QGEN annual interest expense is $43.84 million

    Income tax

    $37.56M
    QGEN annual income tax is $37.56 million

    EBIT & EBITDA

    EBIT

    $164.99M
    QGEN annual earnings before interest & taxes is $164.99 million

    EBITDA

    $368.26M
    QGEN annual EBITDA is $368.26 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.69B
    QGEN annual total assets is $5.69 billion

    Non current assets

    $3.73B
    QGEN annual long term assets is $3.73 billion

    Current assets

    $1.96B
    QGEN annual total current assets is $1.96 billion

    Cash and cash equivalents

    $663.55M
    QGEN annual cash & cash equivalents is $663.55 million

    Accounts receivable

    $349.28M
    QGEN annual accounts receivable is $349.28 million

    Inventory

    $279.26M
    QGEN annual inventory is $279.26 million

    Liabilities

    Total liabilities

    $2.12B
    QGEN annual total liabilities is $2.12 billion

    Long term liabilities

    $1.58B
    QGEN annual total long term liabilities is $1.58 billion

    Current liabilities

    $543.63M
    QGEN annual total current liabilities is $543.63 million

    Accounts payable

    $83.27M
    QGEN annual accounts payable is $83.27 million

    Debt

    Total debt

    $1.39B
    QGEN annual total debt is $1.39 billion

    Total debt 1-year change

    -9.17%
    QGEN annual total debt is down -9.17% year-on-year

    Long term debt

    $1.34B
    QGEN annual long term debt is $1.34 billion

    Short term debt

    $53.48M
    QGEN annual short term debt is $53.48 million

    Equity & Capital

    Shareholders equity

    $3.57B
    QGEN annual stockholders equity is $3.57 billion

    Book value

    $3.57B
    QGEN annual book value is $3.57 billion

    Retained earnings

    $2.45B
    QGEN annual retained earnings is $2.45 billion

    Working capital

    $1.42B
    QGEN annual working capital is $1.42 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $673.55M
    QGEN annual cash flow from operations is $673.55 million

    Cash from operations 1-year change

    +46.6%
    QGEN annual cash flow from operations is up +46.6% year-on-year

    Cash from investing

    -$249.23M
    QGEN annual cash flow from investing activities is -$249.23 million

    Cash from investing 1-year change

    -184.33%
    QGEN annual cash flow from investing activities is down -184.33% year-on-year

    Cash from financing

    -$422.90M
    QGEN annual cash flow from financing activities is -$422.90 million

    Cash from financing 1-year change

    +2.52%
    QGEN annual cash flow from financing activities is up +2.52% year-on-year

    CAPEX

    CAPEX

    $171.24M
    QGEN annual capital expenditures is $171.24 million

    CAPEX 1-year change

    +5.18%
    QGEN annual capital expenditures is up +5.18% year-on-year

    Free Cash Flow

    Free cash flow

    $502.31M
    QGEN annual free cash flow is $502.31 million

    Free cash flow 1-year change

    +69.33%
    QGEN annual free cash flow is up +69.33% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    48.90%
    QGEN annual gross profit margin is 48.90%

    Operating margin

    10.11%
    QGEN annual operating profit margin is 10.11%

    Net margin

    4.23%
    QGEN annual net profit margin is 4.23%

    ROA & ROE

    ROA

    1.42%
    QGEN annual return on assets is 1.42%

    ROE

    2.27%
    QGEN annual return on equity is 2.27%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    126.32
    QGEN price to earnings ratio is 126.32

    PE ratio Sector rank

    94.34%
    QGEN price to earnings ratio is higher than 94.34% of companies in Healthcare sector

    PB Ratio

    PB ratio

    3.29
    QGEN price to book ratio is 3.29

    PB ratio Sector rank

    68.32%
    QGEN price to book ratio is higher than 68.32% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.60
    QGEN price to sales ratio is 5.60

    PS ratio Sector rank

    64.53%
    QGEN price to sales ratio is higher than 64.53% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $11.99B
    QGEN enterprise value is $11.99 billion

    Enterprise value Sector rank

    92.83%
    QGEN enterprise value is higher than 92.83% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    32.21
    QGEN EV/EBITDA is 32.21

    EV/EBITDA Sector rank

    94.81%
    QGEN EV/EBITDA is higher than 94.81% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.61
    QGEN annual current ratio is 3.61

    Quick ratio

    3.09
    QGEN annual quick ratio is 3.09

    Leverage

    Debt to equity

    0.39
    QGEN annual debt to equity ratio is 0.39

    Interest coverage ratio

    3.76
    QGEN annual interest coverage ratio is 3.76

    Risk & Stability

    Piotroski F-Score

    7
    QGEN piotroski f-score is 7

    Altman Z-Score

    4.52
    QGEN altman z-score is 4.52

    Analyst ratings

    Recent major analysts updates

    Jun 26, 25 B of A Securities
    Buy
    Jun 24, 25 Barclays
    Overweight
    Apr 21, 25 Baird
    Neutral
    Apr 4, 25 Redburn Atlantic
    Neutral
    Feb 19, 25 Baird
    Neutral
    Feb 7, 25 UBS
    Neutral
    Jan 6, 25 Morgan Stanley
    Equal-Weight
    Dec 10, 24 Jefferies
    Buy
    Oct 17, 23 JP Morgan
    Overweight
    Sep 26, 23 Citigroup
    Buy

    Institutional Ownership

    Screeners with QGEN included

    Growing Shares Outstanding
    High Piotroski score stocks
    Most recommended stocks
    Best performing stocks last 3 months
    Stocks above SMA 50
    Healthcare sector
    High payout ratio stocks
    All stocks
    Stocks above analysts price target
    High Altman Z score stocks
    • What is the ticker symbol for Qiagen N.V.?
    • Does Qiagen N.V. pay dividends?
    • What sector is Qiagen N.V. in?
    • What industry is Qiagen N.V. in?
    • What country is Qiagen N.V. based in?
    • When did Qiagen N.V. go public?
    • Is Qiagen N.V. in the S&P 500?
    • Is Qiagen N.V. in the NASDAQ 100?
    • Is Qiagen N.V. in the Dow Jones?
    • When was Qiagen N.V.'s last earnings report?
    • When does Qiagen N.V. report earnings?

    What is the ticker symbol for Qiagen N.V.?

    The ticker symbol for Qiagen N.V. is NYSE:QGEN

    Does Qiagen N.V. pay dividends?

    Yes, Qiagen N.V. pays dividends. The last payment was $0.25, with an ex-dividend date on July 2, 2025

    What sector is Qiagen N.V. in?

    Qiagen N.V. is in the Healthcare sector

    What industry is Qiagen N.V. in?

    Qiagen N.V. is in the Diagnostics & Research industry

    What country is Qiagen N.V. based in?

    Qiagen N.V. is headquartered in Netherlands

    When did Qiagen N.V. go public?

    Qiagen N.V.'s initial public offering (IPO) was on June 28, 1996

    Is Qiagen N.V. in the S&P 500?

    No, Qiagen N.V. is not included in the S&P 500 index

    Is Qiagen N.V. in the NASDAQ 100?

    No, Qiagen N.V. is not included in the NASDAQ 100 index

    Is Qiagen N.V. in the Dow Jones?

    No, Qiagen N.V. is not included in the Dow Jones index

    When was Qiagen N.V.'s last earnings report?

    Qiagen N.V.'s most recent earnings report was on May 7, 2025

    When does Qiagen N.V. report earnings?

    The next expected earnings date for Qiagen N.V. is August 6, 2025
    On this page